Migraine treatment is often classified as either acute or preventive treatment. In this slide deck you will find basic concepts and definitions related to modern treatment approaches such as the use of analgesics and NSAIDs, as well as more targeted therapies, such as triptans and CGRP medications. The slide deck also offers a brief introduction to non-pharmacological migraine treatment and current migraine management issues.

This slide deck has been developed for Neurotorium in collaboration with Cambridge Medical – A Prime Global agency and Bjarke Ebert H. Lundbeck A/S. Reviewed by Clinical Research Associate Professor Henrik Winther Schytz, Danish Headache Center, Rigshospitalet Glostrup.

Index for
slide deck

Introduction

Treatment principles
Treatment principles
file_download Download slide in HQ
Historical context for migraine treatment
Historical context for migraine treatment

There have been many historical approaches to treating headaches,[Koehler & Boes, 2010; Pearce, 1986] but modern approaches centre around the use of analgesics, NSAIDs, and more targeted therapies, such as triptans and CGRP related agents.[Martelletti & Giamberardino, 201…

file_download Download slide in HQ

Migraine treatment and management

Migraine treatment and management
Migraine treatment and management
file_download Download slide in HQ
Clinical treatment guidelines
Clinical treatment guidelines

Clinical guidelines for the treatment and management of migraine aim to aid clinicians and thereby improve care. Variations in the weight given to different empirical data and their consequences for clinical practice influence the guidelines, and consequently, at the mome…

file_download Download slide in HQ
European recommendations for treatment and management of migraine in adults
European recommendations for treatment and management of migraine in adults

A consensus statement from 2021, endorsed by the European Headache Federation and the European Academy of Neurology, introduce ten steps to diagnose and manage migraine [Eigenbrodt et al., 2021]. The importance of having a patient centeret approach, prioritizing patient e…

file_download Download slide in HQ
Medication overuse
Medication overuse

Although not fully understood, the use of certain medications in certain individuals is thought to lead to structural and/or functional brain changes, altering their susceptibility to headaches and migraine.[Chong, 2020; Da Silva & Lake, 2014; Kocasoy Orhan, 2019] Over ti…

file_download Download slide in HQ
Treatment of migraine in young people
Treatment of migraine in young people

Migraine in children is a common and disabling disease.[Hershey, 2010; Teleanu, 2016] The prevalence of migraine is thought to increase throughout childhood, and peak post-puberty – perhaps accounted for by menstrual migraine in girls.[Teleanu, 2016] Only a minority of ch…

file_download Download slide in HQ

Pharmacological treatment of acute migraine

Pharmacological treatment of acute migraine
Pharmacological treatment of acute migraine
file_download Download slide in HQ
Strategies for acute treatment of migraine in adults – stepped and stratified care
Strategies for acute treatment of migraine in adults – stepped and stratified care

In stepped care: [Lipton et al., 2000]

• Acute treatment starts with simple analgesics.
• If there’s insufficient or no response, the patient is offered migraine specific treatment.

Stepped care can be applied within or across attacks.[Ashina et al., 2021; Lipton et al., 2…

file_download Download slide in HQ
Acute pharmacological treatment of migraine
Acute pharmacological treatment of migraine

Treatment guidelines and consensus statements for the treatment of migraine has been published by The American Academy of Neurology (AAN), jointly with several organisations including the American Headache Society (AHS), and by the European Headache Federation (EHF), endo…

file_download Download slide in HQ
Analgesics
Analgesics

Both European, American and Canadian treatment guidelines rank the evidence supporting some NSAIDs and other analgesics as high – that is, established as effective for acute migraine treatment based on available evidence.[Marmura et al., 2015; Worthington et al., 2013] Co…

file_download Download slide in HQ
Triptan therapy
Triptan therapy

Treatment guidelines for migraine rank the evidence supporting triptan therapy in the highest tier – that is, established as effective for acute migraine treatment based on available evidence.[Marmura et al., 2015; Worthington et al., 2013] Individual triptan therapies ha…

file_download Download slide in HQ
Efficacy of triptan therapy
Efficacy of triptan therapy

In meta-analyses, most triptan therapies were found to be more effective than NSAIDs, ergots, and certain analgesics.[Cameron et al., 2015; Thorlund et al., 2014] However, among the triptan therapies, multiple-treatment comparison modelling has revealed a hierarchy of eff…

file_download Download slide in HQ
Ditans
Ditans

The cardiovascular adverse effects of triptans – described as their ‘Achilles’ heel’ – led to the development of the ditans (selective serotonin receptor 1F agonists).[González-Hernández et al., 2018] Ditans appear to lack the strong vasoconstrictor effects seen with trip…

file_download Download slide in HQ
Gepants
Gepants

Nonpeptide CGRP receptor agonists are called gepants. Gepants are a newer class of drugs, some of which have recently been approved by the FDA and EMA for the acute treatment of migraine in adults [Ashina et al. 2021; EMA, 2022; FDA, 2022].

References:
Ashina M, Buse DC, A…

file_download Download slide in HQ
Adjunct treatment - Antiemetics (anti-nausea agents)
Adjunct treatment - Antiemetics (anti-nausea agents)

Treatment guidelines recommend the use of antiemetics as adjunctive therapy – an add on to the antimigraine therapy.[Marmura et al., 2015; Worthington et al., 2013] Certain antiemetics are strongly recommended alongside migraine medication in patients with migraine for th…

file_download Download slide in HQ
Other pharmacological treatments
Other pharmacological treatments

Treatment guidelines rank the evidence supporting individual ergot alkaloids as ranging from strong to relatively poor. Some guidelines recommend the use of ergot alkaloids in treating migraine, albeit weakly.[Marmura et al., 2015; Worthington et al., 2013]

However, many …

file_download Download slide in HQ

Related content

image Image Migraine has a detrimental effect on public health, and is a major contributor to disability throughout the world.
Migraine as a global health crisis

An analysis of the Global Burden of Disease (GBD) study showed that migraine and headache disorders were leading causes of years lived with disability, and that for individuals aged 15–49 years, migraine is the leading cause of disability for women.

30.09.2023 Migraine
image Image Migraine attacks can be broken down into four phases: prodrome, aura, headache, and postdrome, as shown in the image.
Proposed phases of a migraine attack

Migraine attacks can be broken down into four phases: prodrome, aura, headache, and postdrome, as shown on the image. The exact timing of each phase is highly variable; the headache phase of a migraine can range from 4–72 hours in adults, and 2–48 hours in children.

29.08.2023 Migraine
image Image The Norwegian HUNT survey found a strong association between chronic headache and musculoskeletal symptoms and joint pain
Prevalence of musculoskeletal symptoms in the HUNT survey

The Norwegian HUNT survey found a strong association between chronic headache and musculoskeletal symptoms and joint pain.

21.07.2023 Migraine